EdwardD.EsplinMDPhD, FACMG

Clinical Genetics, Pediatric Medical Genetics

Clinical Geneticist, Invitae Clinical Scholar, Stanford University Medical School

Dr. Esplin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Edward Esplin is a clinical geneticist and internist with Invitae in San Francisco, CA and holds a research appointment with the Stanford University Medical Center Department of Genetics in Palo Alto, CA. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 12 years. He also speaks multiple languages, including German. He specializes in adult and pediatric medical genetics and is experienced in genetics and genomics, cancer genetics, colorectal cancer, and familial adenomatous polyposis coli.

Stanford Health Care-Sponsored Stanford UniversityResidency, Medical Genetics and Genomics, 2011 - 2013
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Texas Southwestern Medical SchoolClass of 2005
University of UtahBA, Biology-Genetics Emphasis, German Minor, 1992 - 1995

Mead Johnson Travel award Western Society of Pediatric Research, 2013
NIH Clinical Research Loan Repayment Program award National Cancer Institute, 2013-2014
Tashia and John Morgridge Endowed Fellow Spectrum Child Health Research Institute, Stanford University, 2013-2014

PubMed

Journal Articles

Germline Cancer Susceptibility in Individuals with Melanoma
Funchain P, Ni Y, Heald B, Bungo B, Arbesman M, Behera TR, McCormick S, Song JM, Kennedy LB, Nielsen SM, Esplin ED, Nizialek E, Ko J, Diaz-Montero CM, Gastman B, Strat..., J Am Acad Dermatol., 3/19/2024
Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients with Hereditary Cancer Syndrome
Scott Okuno, Luke Mountjoy, Cameron S Thorpe, Edward D Esplin, Robert L Nussbaum, Alan H Bryce, Tanios S Bekaii-Saab, Aleksandar Sekulic, JAMA Oncology

Lectures

Germline multigene panel testing in colorectal cancer: Precision therapy and clinical management implications.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Podcast: Universal Genetic Germline Testing in Solid Tumor Cancer PatientsFebruary 15th, 2023
We Should Rethink Genetic Testing for Breast Cancer PatientsDecember 22nd, 2022
Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor TestingFebruary 6th, 2020
Join now to see all